(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

QFITLIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

QFITLIA

ST13

US500000098054571

Class

5

Filing

98054571

Registration

7820002

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

06/03/2025

Trademark type

Combined

Nice classes

5

Filing date

06/22/2023

Registration date

06/03/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/03/2025

Last transaction

06/03/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/07/2025

First use in commerce

04/07/2025

Drawing code

3

Owner type

03

Owner location

Cambridge, MA

Examiner

THOMAS-RIGGS, LESLIE

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized word "QFITLIA" in dark blue with a yellow circle above the first letter "I," and a row of stylized yellow circles over and extending past the letters "IA".

Holders and representatives

Holders

G. C. (pessoa física)

Representatives

Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancerthrombosisrespiratory diseases; pharmaceutical preparations for the treatment of rare blood disorders; pharmaceutical preparations for the prevention and treatment of infectious diseasesviral and bacterial infections; pharmaceutical preparations for the treatment of lysosomal storage diseases

Publications

History of USPTO decisions and trademark events.

24 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/03/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

06/03/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/12/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/12/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/22/2025

IUAF

USE AMENDMENT FILED

04/15/2025

EISU

TEAS STATEMENT OF USE RECEIVED

04/15/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/10/2025

EX1G

SOU EXTENSION 1 GRANTED

02/07/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/07/2025

EXT1

SOU EXTENSION 1 FILED

11/18/2024

EEXT

SOU TEAS EXTENSION RECEIVED

11/18/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/02/2024

PUBO

PUBLISHED FOR OPPOSITION

04/02/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/13/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/22/2024

DOCK

ASSIGNED TO EXAMINER

02/12/2024

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

12/12/2023

ALIE

ASSIGNED TO LIE

12/12/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/26/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/25/2023

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

07/12/2023

NWAP

NEW APPLICATION ENTERED

06/26/2023

Continuous trademark protection

Get notified about every new filing that threatens QFITLIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.